Chemical activators of Olr150 can engage various cellular mechanisms to enhance the protein's activity. Phorbol 12-myristate 13-acetate (PMA) is one such activator, which directly interacts with protein kinase C (PKC) enzymes leading to their activation. Consequently, PKC can phosphorylate Olr150, which is a crucial post-translational modification that activates Olr150. Forskolin plays a role in elevating cyclic AMP (cAMP) levels within the cell, thereby activating protein kinase A (PKA). Once activated, PKA can target Olr150 for phosphorylation, leading to its activation. Ionomycin acts by increasing intracellular calcium concentrations, which in turn can activate calcium-dependent kinases that phosphorylate and activate Olr150. Another calcium channel agonist, (S)-(+)-Bay K 8644, also raises intracellular calcium levels and indirectly causes the activation of Olr150 by stimulating calcium-responsive kinases. Oleoyl-L-carnitine can activate metabolic pathways, which may involve kinases capable of modifying and activating Olr150, while 1-Oleoyl-2-acetyl-sn-glycerol (OAG) is known to activate PKC that can subsequently phosphorylate Olr150, leading to its activation.
The second set of activators includes bryostatin 1, which binds with PKC, potentially leading to the phosphorylation and activation of Olr150. Inhibitors of phosphatases such as Okadaic Acid and Calyculin A prevent the deactivation of Olr150 by preserving its phosphorylated, active form. Phosphatidic acid has been shown to stimulate the mTOR pathway, which can lead to the phosphorylation and activation of Olr150. The A2A receptor activator, 5-Iodotubercidin, can lead to the activation of PKA, resulting in the phosphorylation and activation of Olr150. Lastly, Anisomycin activates the MAPK pathway, which can also lead to the activation of Olr150 through phosphorylation. These activators collectively employ a variety of cellular signaling pathways to ensure the phosphorylation and sustained activation of Olr150, demonstrating the complex regulation of protein function within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA directly activates PKC enzymes which, when Olr150 is a substrate, results in the phosphorylation and activation of Olr150. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, enabling calcium-dependent kinases to phosphorylate and activate Olr150. | ||||||
1-Oleoyl-2-acetyl-sn-glycerol (OAG) | 86390-77-4 | sc-200417 sc-200417A | 10 mg 50 mg | $119.00 $453.00 | 1 | |
OAG acts on PKC which can then phosphorylate and activate Olr150. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 binds to PKC, and this interaction can lead to the phosphorylation and subsequent activation of Olr150. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits phosphatases that would otherwise dephosphorylate Olr150, maintaining it in an active state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to Okadaic Acid, Calyculin A inhibits phosphatases, thus preserving the phosphorylation and activation state of Olr150. | ||||||
Phosphatidic Acid, Dipalmitoyl | 169051-60-9 | sc-201057 sc-201057B sc-201057A | 100 mg 250 mg 500 mg | $106.00 $244.00 $417.00 | ||
Phosphatidic acid stimulates the mTOR pathway, which can lead to the phosphorylation and activation of Olr150. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
5-Iodotubercidin activates A2A receptors, which can lead to the activation of PKA and subsequent phosphorylation and activation of Olr150. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the MAPK pathway, which can lead to the phosphorylation and activation of Olr150. | ||||||